Tribe Capital Growth Corp I
ATVCU
NASDAQ Capital Market9.83
USD
- -
- -
CIK
0001831874
ISIN
US89601Y2000
CUSIP
89601Y200
Return %
Stock
S&P500
1Y
-0.51
26.53
3Y
-3.63
76.60
5Y
-3.63
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Arjun Sethi
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2700 19th Street San Francisco CA United States of America 94110
- IPO Date
- Mar 5, 2021
- CIK
- 0001831874
- Website
- tribecapitalgrowthcorp.com
- Similar Companies
- Business
- Tribe Capital Growth Corp I (ATVCU) operates as a blank check company, or special purpose acquisition company (SPAC), whose sole business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets. The company focuses on top-decile private technology companies exhibiting inflection points in their growth, with potential to scale towards outsized outcomes through long-term venture capital partnerships; it does not currently engage in any significant operations beyond pursuing and completing an initial business combination. Sponsored by Tribe Arrow Holdings I LLC, an affiliate of data science-driven venture capital firm Tribe Capital Management LLC, the company provides no products or services other than the standard SPAC structure of public units comprising one share of Class A common stock and one-fourth of one redeemable warrant (exercisable at $11.50 per whole share). Tribe Capital Growth Corp I, founded in 2020 and headquartered at 2700 19th Street in San Francisco, California, priced its initial public offering of 27.6 million units at $10.00 apiece in March 2021, raising $276 million in gross proceeds underwritten by Cantor Fitzgerald & Co. In July 2022, the company changed its name to Iris Acquisition Corp, overhauled its management team, relocated its principal executive offices to George Town, Cayman Islands, and shifted its trading symbols accordingly (with ATVCU units ceasing active trading); it announced but later amended a business combination agreement with Liminatus Pharma, LLC in June 2023 that remains pending as of late 2024 per SEC filings, during which time trust assets have been partially liquidated to fund extensions and operations while seeking a de-SPAC target.